Sponsors
The resolution raises national awareness and could improve detection and care for prion diseases, but it provides no new funding or capacity and may concentrate expectations on a single center and raise public concern without delivering actionable resources.
Researchers, clinicians, and families gain greater national visibility and public/clinician awareness of Creutzfeldt–Jakob disease and other prion diseases, which can lead to earlier detection, referral, and tracking of cases.
Patients with prion diseases and their caregivers may benefit from better-aligned research and caregiver support by linking Alzheimer’s/ADRD caregiver research efforts with prion disease study, potentially improving care approaches and family support.
Taxpayers, researchers, and health systems receive a symbolic designation that creates no new funding or legal obligations for surveillance, testing capacity, or research expansion, so awareness may not translate into concrete resources or system improvements.
The bill centers expectations on a single U.S. lab-based monitor (the named center) without providing additional support, which may overburden that institution and limit the country’s laboratory capacity and resilience for prion surveillance and testing.
Hunters, consumers, and rural communities may experience increased alarm or economic concern about zoonotic risks from chronic wasting disease without immediately actionable guidance or resources to address those concerns.
Based on analysis of 2 sections of legislative text.
Introduced November 18, 2025 by Jon Husted · Last progress November 18, 2025
Designates November 12, 2025, as Creutzfeldt-Jakob Disease (CJD) Awareness Day and records congressional findings about CJD, related prion diseases, and surveillance needs. The resolution summarizes case and mortality estimates, the rapid and fatal course of CJD, concerns about zoonotic risk (including chronic wasting disease in cervids), the role of the National Prion Disease Pathology Surveillance Center, and the potential relevance of Alzheimer’s and dementia research and caregiver supports to prion disease work. It does not create new legal rights, require funding, or change existing law.